Global Value Access Strategy Director

Director, T1D (T1D Market Access Lead)

Global Value and Access Strategy (GVAS), Cell and Gene Therapy (CGT)

• Lead payer strategic planning to optimize value and access for early‑stage T1D pipeline assets
• Develop and refine Market Access strategies and Global P&R deliverables across cross‑functional, cross‑regional commercialization processes
• Own Global Payer Plans integrating value evidence generation, strategic pricing, value communications, and stakeholder engagement to support reimbursement and pricing
• Ensure payer positions are represented to internal stakeholders and inform commercialization/development decisions
• Support strategies with market research, environmental data, and commercial/clinical analogs
• Inform financial forecasts
• Partner with HEOR and Global Marketing to optimize value propositions and integrated evidence plans for global access
• Lead capability‑building and thought‑leadership projects for the evolving global payer environment
• Monitor industry and adjust Market Access plans based on market trends, competition, product acceptance, and new releases
• Collaborate with HEOR, International P&R, Corporate Affairs, US Managed Markets, Countries, Marketing, and Clinical Development teams

• 8+ years direct biotech/pharma industry and/or payer experience
• Strong knowledge of US and ex‑US healthcare systems
• Strategic thinker with ability to make pricing/market access recommendations
• Strong quantitative/analytical skills and understanding of pricing & reimbursement/HEOR principles
• General commercialization and drug development experience;
  Cell & Gene Therapy preferred
• Strong cross‑functional matrix collaboration
• Excellent written/oral communication and presentation skills
• Strong relationship building across geographies

• BA/BS in a quantitative field; advanced degree preferred